share_log

中國人壽:2024年第三季度報告

CHINA LIFE: 2024 Third Quarter Report

HKEX ·  Oct 30 18:40

Summary by Futu AI

中國人壽保險股份有限公司(中國人壽)於2024年9月30日發布的財務報告顯示,公司在2024年前三季度實現了顯著的業績增長。報告期內,中國人壽的總收入較去年同期增長14.6%,達到6,481,554萬元。净利潤方面,公司同比增長72.9%,達到566,704萬元。此外,第三季度單季的净利潤更是實現了124.7%的驚人增長,達到192,964萬元。這一強勁的業績增長主要得益於保險業務收入的大幅提升,其中,投資收益率顯著提高,達到了1,767.1%的增長。股東應佔利潤同比增長173.9%,顯示出公司整體財務狀況的穩健。中國人壽的股東結構中,HKSCC Nominees Limited持股比例為25.92%,為公司最大的股東。該財務報告反映了中國人壽在2024年保持了良好的增長勢頭,為投資者帶來了正面信號。
中國人壽保險股份有限公司(中國人壽)於2024年9月30日發布的財務報告顯示,公司在2024年前三季度實現了顯著的業績增長。報告期內,中國人壽的總收入較去年同期增長14.6%,達到6,481,554萬元。净利潤方面,公司同比增長72.9%,達到566,704萬元。此外,第三季度單季的净利潤更是實現了124.7%的驚人增長,達到192,964萬元。這一強勁的業績增長主要得益於保險業務收入的大幅提升,其中,投資收益率顯著提高,達到了1,767.1%的增長。股東應佔利潤同比增長173.9%,顯示出公司整體財務狀況的穩健。中國人壽的股東結構中,HKSCC Nominees Limited持股比例為25.92%,為公司最大的股東。該財務報告反映了中國人壽在2024年保持了良好的增長勢頭,為投資者帶來了正面信號。
China Life Insurance Co., Ltd. (China Life) released its financial report on September 30, 2024, showing significant business performance growth in the first three quarters of 2024. During the reporting period, China Life's total revenue increased by 14.6% compared to the same period last year, reaching 64,815.54 million yuan. In terms of net profit, the company saw a 72.9% year-on-year increase, reaching 5,667.04 million yuan. Furthermore, the net profit for the third quarter alone achieved a staggering growth of 124.7%, reaching 1,929.64 million yuan. This strong performance growth is mainly attributed to a significant increase in insurance business income, with the investment income rate increasing significantly by 1,767.1%. Shareholders' profit increased by 173.9% year-on-year, demonstrating the company's overall solid financial condition. In China Life's shareholder structure, HKSCC Nominees Limited holds a 25.92% stake, making it the largest shareholder of the company. This financial report reflects China Life's positive growth momentum in 2024, sending a positive signal to investors.
China Life Insurance Co., Ltd. (China Life) released its financial report on September 30, 2024, showing significant business performance growth in the first three quarters of 2024. During the reporting period, China Life's total revenue increased by 14.6% compared to the same period last year, reaching 64,815.54 million yuan. In terms of net profit, the company saw a 72.9% year-on-year increase, reaching 5,667.04 million yuan. Furthermore, the net profit for the third quarter alone achieved a staggering growth of 124.7%, reaching 1,929.64 million yuan. This strong performance growth is mainly attributed to a significant increase in insurance business income, with the investment income rate increasing significantly by 1,767.1%. Shareholders' profit increased by 173.9% year-on-year, demonstrating the company's overall solid financial condition. In China Life's shareholder structure, HKSCC Nominees Limited holds a 25.92% stake, making it the largest shareholder of the company. This financial report reflects China Life's positive growth momentum in 2024, sending a positive signal to investors.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.